Paris, France – 4 septembre 2025 – Primaa, a pioneer in AI-powered pathology solutions, is proud to announce that its flagship tools, Cleo Breast (CE-IVDR) and Cleo Skin (RUO), will be integrated into PathAI’s AISight Dx1 Image Management System (IMS). This milestone reinforces Primaa’s mission to redefine dermatopathology and breast pathology practices by providing pathologists with validated, AI-driven support tools directly in their daily workflows.
Through this new collaboration, pathologists using AISight Dx will benefit from Primaa’s AI-powered algorithms, Cleo Breast and Cleo Skin. The algorithms aim to enhance accuracy and efficiency in the detection, classification, and quantification of tissue lesions.

“Our integration into PathAI’s AISight Dx IMS marks a major step forward for Primaa” said Fanny Sockeel, CEO at Primaa. “By combining our Cleo Breast and Cleo Skin algorithms with PathAI’s cutting-edge digital pathology platform, we are empowering pathologists with the tools they need to achieve greater precision and ultimately improve outcomes.”

“We are excited to welcome Primaa to the AISight Dx platform” said Andy Beck, MD, PhD, Co-founder and CEO of PathAI. “Partnering with innovators like Primaa ensures we seamlessly deliver our customers the latest technologies directly through our AI-native IMS platform.”

1 AISight® Dx is CE‑IVD–marked for primary diagnosis in the EEA, UK, and Switzerland and FDA-cleared for primary diagnosis in the US.

About Primaa
Primaa leverages advanced AI algorithms to enhance the accuracy and efficiency of biomarker detection in dermatopathology and breast pathology. Its flagship tools, Cleo Breast and Cleo Skin, support pathologists in delivering faster, more reliable diagnoses and redefining how tissue lesions are assessed.

About PathAI
PathAI is a leading provider of integrated AI and digital pathology solutions dedicated to transforming diagnostic accuracy and operational efficiency in pathology labs worldwide. Through innovative technologies and strategic partnerships, PathAI aims to enhance patient outcomes and drive the future of medical diagnostics. For more information, please visit pathai.com